MPXV M1R (AA 1-182) Antikörper
Kurzübersicht für MPXV M1R (AA 1-182) Antikörper (ABIN7570374)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-182
-
Verwendungszweck
- Anti-Monkeypox virus/MPXV M1R Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Monkeypox virus/MPXV M1R (Met1-Thr182).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
-
Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus." in: Cell reports, Vol. 43, Issue 6, pp. 114269, (2024) (PubMed).
: "Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice." in: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 32, Issue 6, pp. 1779-1789, (2024) (PubMed).
: "
-
Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus." in: Cell reports, Vol. 43, Issue 6, pp. 114269, (2024) (PubMed).
-
- MPXV M1R
-
Hintergrund
- M1R, Monkeypox virus (MPXV)
Target
-